Showing results (161-170 of 375) with videos related to

Sort By:
Pageof 38
Statistics in Medicine|May 31, 2018
High-dimensional variable selection and prediction under competing risks with application to SEER-Medicare linked dataJiayi Hou, Anthony Paravati, Jue Hou, et al.
Leukemia Research|December 23, 2003
Inhibitory effects of phaseolotoxin on proliferation of leukemia cells HL-60, K-562 and L1210 and pancreatic cells RIN-m5FAndré S Bachmann, Ronghui Xu, Lal Ratnapala, et al.
Neuroreport|June 10, 2010
Reduced hypocretin (orexin) levels in dementia with Lewy bodiesStephanie Lessig, Kiren Ubhi, Douglas Galasko, et al.
Movement Disorders Clinical Practice|January 11, 2021
Delineation of Apathy Subgroups in Parkinson's Disease: Differences in Clinical Presentation, Functional Ability, Health-related Quality of Life, and Caregiver BurdenGraham M L Eglit, Francesca Lopez, Dawn M Schiehser, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 6, 2018
Medication Management Capacity and Its Neurocognitive Correlates in Huntington's DiseaseCatherine A Sumida, Emily J Van Etten, Francesca V Lopez, et al.
Movement Disorders Clinical Practice|July 10, 2019
Factor Analysis of the Apathy Scale in Parkinson's DiseaseFrancesca V Lopez, Graham M L Eglit, Dawn M Schiehser, et al.
Plos One|March 3, 2011
Neurobehavioral mechanisms of temporal processing deficits in Parkinson's diseaseDeborah L Harrington, Gabriel N Castillo, Paul A Greenberg, et al.
Journal of Clinical and Experimental Neuropsychology|May 9, 2024
The relationship between objective and subjective executive function in Parkinson's diseaseMolly Split, Celina Pluim McDowell, Francesca V Lopez, et al.
Journal of Huntington'S Disease|September 3, 2019
Recall and Recognition Discriminability in Parkinson's Disease and Huntington's DiseaseEmily J Van Etten, Lisa V Graves, Brad Taylor, et al.
Pageof 38